• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-连环蛋白在乳腺癌不同亚型中的表达及其临床意义。

The expression of β-catenin in different subtypes of breast cancer and its clinical significance.

作者信息

Li Shuguang, Li Shanshan, Sun Ying, Li Li

机构信息

Department of Medical Oncology, Cancer Center, Qilu Hospital of Shandong University, Wenhuaxi Road 107#, 250012, Jinan, China.

出版信息

Tumour Biol. 2014 Aug;35(8):7693-8. doi: 10.1007/s13277-014-1975-0. Epub 2014 May 8.

DOI:10.1007/s13277-014-1975-0
PMID:24801904
Abstract

The Wnt/β-catenin signaling pathway is implicated in mammary oncogenesis. Reports of β-catenin expression and its association with outcome in breast cancer are controversial. This study was performed to address the distribution of β-catenin expression in invasive breast cancer and the correlation between β-catenin expression and survival of breast cancer patients, and to determine whether β-catenin was specifically activated in any molecular subtypes. Immunohistochemistry was performed on a tissue microarray containing 169 invasive breast cancers to detect expression of β-catenin. One hundred thirty one of the 169 patients were followed up. Correlation between β-catenin expression and different molecular subtypes was determined using chi-square analysis. Overall survival (OS) was analyzed by Kaplan-Meier method with log-rank test. The invasive breast cancer displayed the different patterns of β-catenin expression from normal tissues with significantly increased cytoplasmic and nuclear staining of β-catenin. Aberrant β-catenin expression was observed in 109 in the 169 cases (64.50 %), and there was no difference in β-catenin expression in the four molecular subtypes. Furthermore, aberrant β-catenin expression was significantly associated with adverse outcome not only in the entire cohort but also in each of the different molecular subtypes. β-catenin activation is preferentially found and is associated with a poor clinical outcome in invasive breast cancer independent of molecular subtype.

摘要

Wnt/β-连环蛋白信号通路与乳腺癌发生有关。关于β-连环蛋白在乳腺癌中的表达及其与预后的关系的报道存在争议。本研究旨在探讨β-连环蛋白在浸润性乳腺癌中的表达分布、β-连环蛋白表达与乳腺癌患者生存率的相关性,并确定β-连环蛋白在任何分子亚型中是否被特异性激活。对包含169例浸润性乳腺癌的组织芯片进行免疫组织化学检测β-连环蛋白的表达。对169例患者中的131例进行随访。采用卡方分析确定β-连环蛋白表达与不同分子亚型之间的相关性。采用Kaplan-Meier法和对数秩检验分析总生存期(OS)。浸润性乳腺癌显示出与正常组织不同的β-连环蛋白表达模式,β-连环蛋白的细胞质和细胞核染色显著增加。169例中有109例(64.50%)观察到β-连环蛋白异常表达,四种分子亚型中β-连环蛋白表达无差异。此外,β-连环蛋白异常表达不仅在整个队列中,而且在每种不同分子亚型中均与不良预后显著相关。在浸润性乳腺癌中,无论分子亚型如何,均优先发现β-连环蛋白激活,且与不良临床预后相关。

相似文献

1
The expression of β-catenin in different subtypes of breast cancer and its clinical significance.β-连环蛋白在乳腺癌不同亚型中的表达及其临床意义。
Tumour Biol. 2014 Aug;35(8):7693-8. doi: 10.1007/s13277-014-1975-0. Epub 2014 May 8.
2
PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.人乳腺癌中的PPARγ与Wnt/β-连环蛋白信号通路:表达模式、分子相互作用及临床/预后相关性
J Cancer Res Clin Oncol. 2009 Nov;135(11):1551-9. doi: 10.1007/s00432-009-0602-8. Epub 2009 Jun 3.
3
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.Wnt/β-catenin 通路的激活在基底样乳腺癌中富集,并预示着不良预后。
Am J Pathol. 2010 Jun;176(6):2911-20. doi: 10.2353/ajpath.2010.091125. Epub 2010 Apr 15.
4
Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.Wnt/β-连环蛋白信号通路在正常和肿瘤性乳腺组织中的激活状态:与人及鼠的 HER2/neu 表达的关系。
PLoS One. 2012;7(3):e33421. doi: 10.1371/journal.pone.0033421. Epub 2012 Mar 23.
5
Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.Wnt/β-连环蛋白信号通路在食管鳞状细胞癌中的临床病理意义
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3045-53. eCollection 2015.
6
SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.SOX9 调控低密度脂蛋白受体相关蛋白 6(LRP6)和 T 细胞因子 4(TCF4)的表达以及乳腺癌中的 Wnt/β-连环蛋白激活。
J Biol Chem. 2013 Mar 1;288(9):6478-87. doi: 10.1074/jbc.M112.419184. Epub 2013 Jan 10.
7
LGR5 overexpression confers poor relapse-free survival in breast cancer patients.LGR5 过表达与乳腺癌患者无复发生存不良相关。
BMC Cancer. 2018 Feb 22;18(1):219. doi: 10.1186/s12885-018-4018-1.
8
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome.浸润性乳腺癌中磷酸化β-连环蛋白亚细胞分布与其表型及临床结局的相关性研究。
Mod Pathol. 2006 Apr;19(4):556-63. doi: 10.1038/modpathol.3800562.
9
Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.转导素(β)样1 X连锁受体1通过激活β-连环蛋白信号通路促进人乳腺癌的增殖和致瘤性。
Breast Cancer Res. 2014 Oct 24;16(5):465. doi: 10.1186/s13058-014-0465-z.
10
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.乳腺浸润性导管癌中的Wnt信号通路:β-连环蛋白、散乱蛋白与细胞周期蛋白D1表达之间的关系
Oncology. 2007;73(1-2):112-7. doi: 10.1159/000120999. Epub 2008 Mar 13.

引用本文的文献

1
and mutations as drivers of paclitaxel resistance in breast cancer cells.以及作为乳腺癌细胞中紫杉醇耐药驱动因素的突变。
Oncol Lett. 2025 May 2;30(1):324. doi: 10.3892/ol.2025.15070. eCollection 2025 Jul.
2
Defining the Molecular Intricacies of Human Papillomavirus-Associated Tonsillar Carcinoma.定义人乳头瘤病毒相关扁桃体癌的分子复杂性。
Cancer Control. 2025 Jan-Dec;32:10732748241310932. doi: 10.1177/10732748241310932. Epub 2025 May 7.
3
Patient-Derived Breast Cancer Bone Metastasis Model Using Bone-Mimetic Nanoclay Scaffolds.

本文引用的文献

1
β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.β-连环蛋白信号转导是 ErbB2 介导的乳腺肿瘤进展中的关键事件。
Cancer Res. 2013 Jul 15;73(14):4474-87. doi: 10.1158/0008-5472.CAN-12-3925. Epub 2013 May 29.
2
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.Wnt 信号通路在体外获得性他莫昔芬耐药乳腺癌模型中上调。
BMC Cancer. 2013 Apr 2;13:174. doi: 10.1186/1471-2407-13-174.
3
Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.
使用仿骨纳米粘土支架构建的患者来源的乳腺癌骨转移模型
J Tissue Eng Regen Med. 2023 Mar 11;2023:5753666. doi: 10.1155/2023/5753666. eCollection 2023.
4
Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long Non-coding RNA in Breast Cancer Metastasis.乳腺癌亚型的分子动力学:FAM83H-AS1长链非编码RNA在乳腺癌转移中的作用
Breast Cancer Res Treat. 2025 Apr;210(3):645-659. doi: 10.1007/s10549-024-07603-4. Epub 2025 Feb 1.
5
Biomarkers derived from CmP signal network in triple negative breast cancers.源自三阴性乳腺癌中CmP信号网络的生物标志物。
Transl Breast Cancer Res. 2023 Jul 30;4:21. doi: 10.21037/tbcr-23-30. eCollection 2023.
6
ELK3-ID4 axis governs the metastatic features of triple negative breast cancer.ELK3-ID4 轴调控三阴性乳腺癌的转移特征。
Oncol Res. 2023 Nov 15;32(1):127-138. doi: 10.32604/or.2023.042945. eCollection 2023.
7
Obesity Associated with Prediabetes Increases the Risk of Breast Cancer Development and Progression-A Study on an Obese Rat Model with Impaired Glucose Tolerance.肥胖与糖尿病前期相关,增加乳腺癌发生和进展的风险-糖耐量受损肥胖大鼠模型研究。
Int J Mol Sci. 2023 Jul 14;24(14):11441. doi: 10.3390/ijms241411441.
8
Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells.NONO 蛋白表达和稳定性促进人乳腺癌细胞的致瘤性和 Akt/MAPK/β-catenin 通路的激活。
Cell Commun Signal. 2023 Jun 27;21(1):157. doi: 10.1186/s12964-023-01179-0.
9
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.在 ER-HER2+ 乳腺癌细胞中抑制甘油磷酸二酯酶 EDI3,可降低对 HER2 靶向治疗耐药的细胞活力和肿瘤生长。
J Exp Clin Cancer Res. 2023 Jan 20;42(1):25. doi: 10.1186/s13046-022-02578-w.
10
The role of R-spondin proteins in cancer biology.R -spondin 蛋白在癌症生物学中的作用。
Oncogene. 2021 Nov;40(47):6469-6478. doi: 10.1038/s41388-021-02059-y. Epub 2021 Oct 18.
Wnt3 的表达激活了 Wnt/β-catenin 通路,并促进了曲妥珠单抗耐药的 HER2 过表达乳腺癌细胞中的 EMT 样表型。
Mol Cancer Res. 2012 Dec;10(12):1597-606. doi: 10.1158/1541-7786.MCR-12-0155-T. Epub 2012 Oct 15.
4
Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.Nek2 和 β-连环蛋白在乳腺癌中的异常表达:临床病理相关性。
Histopathology. 2011 Oct;59(4):631-42. doi: 10.1111/j.1365-2559.2011.03941.x.
5
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.β-连环蛋白通路在乳腺癌中的激活与三阴性表型相关,但与 CTNNB1 突变无关。
Mod Pathol. 2011 Feb;24(2):209-31. doi: 10.1038/modpathol.2010.205. Epub 2010 Nov 12.
6
Key signaling nodes in mammary gland development and cancer: β-catenin.乳腺发育和癌症中的关键信号节点:β-连环蛋白。
Breast Cancer Res. 2010;12(6):213. doi: 10.1186/bcr2723. Epub 2010 Nov 3.
7
Genome profiling of ERBB2-amplified breast cancers.ERBB2 扩增型乳腺癌的基因组分析。
BMC Cancer. 2010 Oct 8;10:539. doi: 10.1186/1471-2407-10-539.
8
Wnt and mammary stem cells: hormones cannot fly wingless.Wnt 与乳腺干细胞:激素无法无中生有。
Curr Opin Pharmacol. 2010 Dec;10(6):643-9. doi: 10.1016/j.coph.2010.07.004.
9
A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.一个 Wnt 开启的机会:在乳腺癌中靶向 Wnt/β-catenin 通路。
Curr Drug Targets. 2010 Sep;11(9):1074-88. doi: 10.2174/138945010792006780.
10
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.Wnt/β-catenin 通路的激活在基底样乳腺癌中富集,并预示着不良预后。
Am J Pathol. 2010 Jun;176(6):2911-20. doi: 10.2353/ajpath.2010.091125. Epub 2010 Apr 15.